Precigen, Inc.
PGEN
$4.15
$0.071.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 146.73% | 59.32% | -1.37% | -22.80% | -36.86% |
| Total Other Revenue | -- | 40.00% | 44.00% | -11.76% | -100.00% |
| Total Revenue | 146.73% | 59.20% | -1.12% | -22.76% | -36.95% |
| Cost of Revenue | -12.93% | -55.64% | -48.71% | -57.16% | -64.05% |
| Gross Profit | 38.63% | 63.05% | 52.88% | 60.24% | 66.38% |
| SG&A Expenses | 69.83% | 56.52% | 23.57% | 11.75% | 2.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.90% | 14.76% | -0.63% | 1.89% | 3.66% |
| Operating Income | -12.56% | -12.91% | 0.61% | -3.38% | -6.50% |
| Income Before Tax | -95.77% | -74.40% | 9.36% | -62.74% | -32.86% |
| Income Tax Expenses | 100.17% | 95.88% | 96.50% | -308.33% | -291.48% |
| Earnings from Continuing Operations | -98.55% | -76.88% | 8.04% | -61.65% | -31.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.55% | -76.88% | 8.04% | -61.65% | -31.63% |
| EBIT | -12.56% | -12.91% | 0.61% | -3.38% | -6.50% |
| EBITDA | -14.66% | -16.77% | -3.70% | -7.23% | -9.63% |
| EPS Basic | -190.15% | -155.65% | 20.77% | -46.69% | -22.65% |
| Normalized Basic EPS | -122.20% | -116.83% | -15.29% | -29.58% | -2.87% |
| EPS Diluted | -190.15% | -155.65% | 20.77% | -46.69% | -22.65% |
| Normalized Diluted EPS | -122.20% | -116.83% | -15.29% | -29.58% | -2.87% |
| Average Basic Shares Outstanding | 16.92% | 16.00% | 16.05% | 12.13% | 9.78% |
| Average Diluted Shares Outstanding | 16.92% | 16.00% | 16.05% | 12.13% | 9.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |